5 completed, 1 withdrawn. 3 Phase 3, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 4 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Desonide: new trials by email Literature Review of Desonide trials Research Report on Desonide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Vasoconstriction Properties of MC2-01 Cream MC2-01 Cream, Clobetasol Propionate 0.05% Lotion, Betamethasone Dipropionate 0.05% Cream - Vasoconstriction | Phase 1 | Completed | MC2 Therapeutics | 36 | 2018-11-05 | 2020-01-09 |
| 8-Week Atopic Dermatitis (AD) Treatment Study Investigational OTC Cream, 0.05% Desonide, Placebo Cream - Atopic Dermatitis Eczema | Phase 3 | Completed | Procter and Gamble | 65 | 2017-11-27 | 2020-12-17 |
| Proton Pump Inhibitors Use in Patients With Psoriasis esomeprazole, desonide - Psoriasis | Phase 4 | Withdrawn | EMS | 2016-01-01 | 2022-08-05 | |
| Emollients in the Management of Atopic Dermatitis glycerol, paraffin (liquid and white soft), Atopiclair®, Locatop@ - Atopic Dermatitis | Phase 3 | Completed | Pierre Fabre Medicament | 347 | 2013-02-01 | 2014-02-19 |
| Efficacy Emollient on Xerosis in Children With Atopic Dermatitis V0034CR01B, Vehicle cream, desonide 0.1% cream - Atopic Dermatitis | Phase 3 | Completed | Pierre Fabre Medicament | 251 | 2011-11-01 | 2013-02-21 |
| Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation Desonide, Niacinamide, Placebo - Hyperpigmentation | Phase 4 | Completed | Universidad Autonoma de San Luis Potosí | 28 | 2011-07-01 | 2012-11-29 |
Dermatitis (2) · Dermatitis, Atopic (2) · Eczema (2) · Hyperpigmentation (1) · Pruritus (1) · Psoriasis (1)
Pierre Fabre Medicament (2) · EMS (1) · MC2 Therapeutics (1) · Procter and Gamble (1) · Universidad Autonoma de San Luis Potosí (1)
France (3) · Estonia (2) · Lithuania (2) · Poland (2) · Romania (2) · Mexico (1) · United States (1)
Amanda Salisbury, BSN (1) · Bertha Torres-Alvarez, MD (1)